Robert Dutcher, PharmD

home / authors / robert-dutcher-pharmd

Articles

IDSA Guideline Recommendations: Treating Multi-Drug Resistant and Difficult to Treat Resistant P. aeruginosa

IDSA Guideline Recommendations: Treating Multi-Drug Resistant and Difficult to Treat Resistant P. aeruginosa

Robert Dutcher, PharmD
June 4th 2025

Infectious Disease Society of America guidance defines difficult-to-treat resistant Pseudomonas aeruginosa as resistance to all first-line agents.

Read More

Site Logo

Guidelines Recommend ACE Inhibitor or ARB for Heart Failure

Robert Dutcher, PharmD
October 1st 2007

Dr. Dutcher is a registered pharmacist based in Punta Gorda, Fla.

Read More

Site Logo

When the Patient Won't Take the Medicine

Robert Dutcher, PharmD
February 1st 2007

Read More

Site Logo

Medication Reconciliation Is Key

Robert Dutcher, PharmD
December 1st 2006

Read More

Latest Updated Articles

Emerging Data: Impacts of ROCKstar and AGAVE-201
Published: May 30th 2025 | Updated: June 5th 2025
Emerging Data: Impacts of ROCKstar and AGAVE-201
Mother holding baby's foot with measles spots | Image Credit: © rostock-studio - stock.adobe.com
Published: April 18th 2025 | Updated: April 21st 2025
Measles Cases Climb to 800 in United States as Outbreak Spreads Across Borders
Anatomy of Human Heart on medical background. 3d render - Image credit: ckybe | stock.adobe.com
Published: March 10th 2025 | Updated: March 21st 2025
Pharmacists Will Play an Essential Role in Optimizing Vutrisiran Therapy for ATTR-CM
Image credit: toeytoey | stock.adobe.com
Published: March 12th 2025 | Updated: March 18th 2025
MDMA Rejected: The Story of a Study Participant Entrenched in Ethical Violations
Blood test for graft-vs-host-disease (GVHD) -- Image credit: MdBabul | stock.adobe.com
Published: February 26th 2025 | Updated: March 14th 2025
Navigating Steroid-Refractory GVHD Treatment: A Pharmacist’s Guide to Medication Management
fda on paper texture - Image credit: Araki Illustrations | stock.adobe.com
Published: March 7th 2025 | Updated: March 10th 2025
FDA Approves Interchangeable Biosimilar to Xolair